ZINC (Hospira, Inc.)


Welcome to the PulseAid listing for the ZINC drug offered from Hospira, Inc.. This Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: ZINC CHLORIDE
SUBSTANCE NAME: ZINC CHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00


ZINC HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZINC from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-4090_c6418e26-4e62-49bc-b3c8-f027e5815bc4
PRODUCT NDC: 0409-4090
APPLICATION NUMBER: NDA018959

Other ZINC CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.ZINC
Rxhomeo Private Limited d.b.a. Rxhomeo, IncZINCUM MURIATICUM